Log in

Relevant bibliographies by topics / Biotechnology business / Dissertations / Theses

To see the other types of publications on this topic, follow the link: Biotechnology business.

Dissertations / Theses on the topic 'Biotechnology business'

Author: Grafiati

Published: 3 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 dissertations / theses for your research on the topic 'Biotechnology business.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.

1

LORENZI, VALERIA. "Business development in Global Markets. The case of biotechnology." Doctoral thesis, Università degli Studi di Milano-Bicocca, 2014. http://hdl.handle.net/10281/50557.

Full text

Abstract:

High levels of scientific and technological complexity along with extremely uncertain and long R&D processes make firms growth in the biotechnology industry a particularly tough goal to pursue. In such a context, globalization requires companies to operate according to a competitive market-oriented management (market-driven management), which leads to the development of an “outside-in” thinking process. It follows that organizations able to timely monitor information derived from the outside, have a greater aptness to perform more effectively than competitors in the identification and managem

APA, Harvard, Vancouver, ISO, and other styles

2

Lawrence, Ian T. "The finance of biotechnology : investment in new biotechnology firms by British venture capitalists-attitudes to, and evaluation of, business proposals." Thesis, Aston University, 1988. http://publications.aston.ac.uk/10830/.

Full text

Abstract:

A notable feature of the recent commercialisation of biotechnology has been the success of 200 or so new firms, established in America since 1976, in exploiting specialised market niches. A key factor in their formation has been the ready availability of venture capital funding. These firms have been instrumental in establishing America's lead in exploiting biotechnology. It is this example which Britain has attempted to emulate as part of its strategy for developing its own biotechnology capabilities. This thesis investigated some aspects of the relationship between biotechnology and venture

APA, Harvard, Vancouver, ISO, and other styles

3

Muresu, Fredrik, and Gustaf Meyer. "How do buy-recommendations on Swedish biotechnology companies perform?" Thesis, Uppsala universitet, Företagsekonomiska institutionen, 2021. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-450061.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Vigorito, Anthony J. "Agricultural biotechnology, corporate hegemony, and the industrial colonization of science /." The Ohio State University, 2002. http://rave.ohiolink.edu/etdc/view?acc_num=osu1486459267522341.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Nel, Izak Bartholomeus Jacques. "The relationship between global pharmaceutical companies and the biotechnology industry in South Africa : implications for an emerging biotechnology industry in South Africa." Thesis, Stellenbosch : Stellenbosch University, 2003. http://hdl.handle.net/10019.1/53672.

Full text

Abstract:

Mini-study project (MBA)--University of Stellenbosch, 2003.<br>ENGLISH ABSTRACT: This report reviews the global and South African pharmaceutical and biotechnology industries and provides an overview of the changes taking place within these two industries. It highlights the impact this relationship will have on a developing South African biotechnology industry. Since the 1980s the pharmaceutical industry has experienced phenomenal growth in sales and profits. By the mid 1990s drug sales exceeded USD250 billion. Today the pharmaceutical industry is dominated by multi-national corporations

APA, Harvard, Vancouver, ISO, and other styles

6

NÄTTERLUND, LINA, and Lärkert Julia Sigerud. "Business Incubation Success in Biotechnology : How Should Bio-incubator Performance be Assessed?" Thesis, KTH, Entreprenörskap och Innovation, 2014. http://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-147769.

Full text

Abstract:

University business incubators (UBIs) are organizations that provide new startup companies with a support environment. However, there are split opinions on the UBIs’ contributions to the startups and the regional economy and, consequently, there are also split opinions on how to assess UBI performance. According to the resource-based view (RBV), a company’s competitive advantage results from the various resources the company has access to. The biotechnology industry is characterized by high research intensity, weak entrepreneurial and managerial skills of the entrepreneur, huge capital requir

APA, Harvard, Vancouver, ISO, and other styles

7

Chataway, Joanna Caroline. "The making of biotechnology : a case study of radical innovation." Thesis, Open University, 1991. http://oro.open.ac.uk/57345/.

Full text

Abstract:

This study examines decision making in large and small firms undertaking biotechnology innovation and identifies factors influencing innovation. It also considers aspects of environments external to firms, but relevant to the process of innovation. The study suggests that innovation is best understood as process of change both within the firm and in the external environment. Factors internal to firms influencing key decisions included economic and political evaluations, company culture, organization, and in large firms, previous areas of corporate activity. A scarcity of appropriate knowledge

APA, Harvard, Vancouver, ISO, and other styles

8

Baer, Justin D. "Strategy and structure in interfirm alliances : the U.S. biotechnology industry, 1980-1992 /." Thesis, Connect to this title online; UW restricted, 2002. http://hdl.handle.net/1773/8855.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Hansen, Zeynep. "Contractual arrangements under technological uncertainty: Analysis of pharmaceutical and biotechnology collaborations." Diss., The University of Arizona, 2002. http://hdl.handle.net/10150/280007.

Full text

Abstract:

This dissertation investigates the conditions that shape the governance structure of contractual agreements and how different contract types address the potential problems that can arise in R&D partnerships under technological uncertainty. The motivation for this study arises from the emergence of new forms of R&D organization to cope with challenges as well as opportunities created by rapid technological change. This dissertation demonstrates the significance of technological uncertainty in determining the observed variety of contractual arrangements in the biotechnology industry. It also sho

APA, Harvard, Vancouver, ISO, and other styles

10

Nilsson, Anna S. "Interaction between researchers, firm managers and venture capitalists : the essence of biotechnology business /." Stockholm : Karolinska University Press, 2001. http://diss.kib.ki.se/2001/91-7349-049-0/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Smit, Barend Schalk. "The biotechnology revolution and its potential impact on the South African economy." Thesis, Stellenbosch : Stellenbosch University, 2004. http://hdl.handle.net/10019.1/50120.

Full text

Abstract:

Thesis (MBA)--Stellenbosch University, 2004.<br>ENGLISH ABSTRACT: In the history of the world, technological change has always played a central role in the advancement of the global economy. Every now and then a technological development comes along that causes a quantum leap in the technological progress of the world. Such were the mechanical developments that led to the industrial revolution, or the electronic developments that led to the more recent information technology revolution. A characteristic of these developments is its profound impact on the world economy. An explosion of ne

APA, Harvard, Vancouver, ISO, and other styles

12

Gurau, Calin. "The international marketing strategies of UK small and medium sized biotechnology enterprises (SMBEs)." Thesis, Southampton Solent University, 2001. http://ssudl.solent.ac.uk/1236/.

Full text

Abstract:

Considering the importance of international activities for the small and medium-sized firms in the modern economy, the present research project tries to identify the degree in internationalisation and the main international marketing strategies used by the small and medium-sized biotechnology enterprises (SMBEs). The biotechnology sector cannot be considered as a homogenous industry, but rather as a series of different industrial applications centred around the specific use of biological organisms in producing and improving existent products and processes. Biotechnology is also a high technolo

APA, Harvard, Vancouver, ISO, and other styles

13

Nguyen, Quang A. "Review of environmental impacts and applications of biotechnology in the pulp and paper industry in Canada." Thesis, University of Ottawa (Canada), 1991. http://hdl.handle.net/10393/7935.

Full text

Abstract:

This thesis examines the environmental issues facing the Canadian pulp and paper industry and the potential application of biotechnology to solve some of these problems and contribute to a sustainable growth in the future. Biotechnology can offer a wide scope of applications including: (1) Plant biotechnology: silvicluture, reforestation, replacement of chemical pesticides with biological control agents. (2) Biopulping and biobleaching: reduce the amount of polluting chemicals used in the production of pulp. (3) Effluent treatment: micro-organisms can be selected to treat mill effluent more ef

APA, Harvard, Vancouver, ISO, and other styles

14

Ali, Ayfer Habib. "From Idea to Product - Translating Knowledge between the Lab and the Clinic." Thesis, Harvard University, 2012. http://dissertations.umi.com/gsas.harvard:10492.

Full text

Abstract:

This dissertation is composed of three essays looking at innovation at Academic Medical Centers. It tries to empirically explore the problem of translating knowledge from the laboratory bench to the clinic and from the clinic to the bench. Chapter 1, co-authored with Iain Cockburn, establishes the importance of inhouse complementary knowledge in firm decision to license an invention from an Academic Medical Center. By using patent data to describe the technology portfolio of firms who look at patents and then decide whether to license them or not we are able to provide a description of demand

APA, Harvard, Vancouver, ISO, and other styles

15

Williams, Ian D. "University-industry-relations - their role in technological innovation : the case of biotechnology in the UK." Thesis, Aston University, 1990. http://publications.aston.ac.uk/10837/.

Full text

Abstract:

Biotechnology is one of a series of new `generic technologies' that have been identified by western governments as possessing stategic economic opportunities. In this thesis I examine the characteristics of the technology and the government policies that have been developed to both promote and exploit the underpinning scientific research for biotechnology. The approach I have taken involves an in-depth analysis of the role of university-industry research relations in the development of biotechnology. To this end I carried out a detailed survey of biotechnology companies in the UK on the nature

APA, Harvard, Vancouver, ISO, and other styles

16

Ejerhed, Johan. "Public-Private VC-funding : an oxymoron? Starting biotechnology ventures in Mecklenburg-Western Pomerania." Thesis, Linköping University, Department of Management and Economics, 2004. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-2357.

Full text

Abstract:

<p>The purpose of this Master's Thesis is to investigate the outlooks for a seed stage venture capital fund investing in biotechnology-related spinouts from public research to be established in Mecklenburg-Western Pomerania, Germany. Recommendations on how to improve any discovered deficits of the fund's prerequisites are also to be presented. </p><p>Analyses showed that the spinout potential of the research in the region is weak. The entrepreneurial prerequisites of the researchers, in terms of previous experience, business knowledge and a track record that would vouch for them being suitable

APA, Harvard, Vancouver, ISO, and other styles

17

Sardana, Deepak, and deepaks@agsm edu au. "Empirical insights into the black box of decision-making in new ventures : a study based on biotechnology companies in Australia and India." The Australian National University. National Graduate School of Management, 2007. http://thesis.anu.edu.au./public/adt-ANU20080115.153853.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Bilotta, Rocky Graziano. "Temporal Changes in the Spatial Distribution of Venture Capital Investment to Biotechnology Companies within the United States." Digital Commons @ East Tennessee State University, 2008. https://dc.etsu.edu/etd/1902.

Full text

Abstract:

The objective of this research is to investigate temporal changes in the spatial distribution of venture capital investments to biotechnology companies within the United States. Data included venture capital to biotech investments from 1995 to 2005. Venture capital and biotech data from the Money Tree Report, were gathered, analyzed, and mapped to show if a spatial relationship exists. The research examined venture capital investments at both the individual and the aggregated levels. At the individual level, the research examined whether the amount of investments a biotech company receives are

APA, Harvard, Vancouver, ISO, and other styles

19

Jones, Mark Peter. "Biotech's perfect climate : the Hybritech story /." Diss., Connect to a 24 p. preview or request complete full format. Access restricted to UC IP addresses, 2005. http://wwwlib.umi.com/cr/ucsd/fullcit?p3160338.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Andersson, Per. "The emergence and change of Pharmacia Biotech 1959-1995 : the power of the slow flow and the drama of great events." Doctoral thesis, Handelshögskolan i Stockholm, Marknadsföring, Distributionsekonomi och Industriell Dynamik (D), 1996. http://urn.kb.se/resolve?urn=urn:nbn:se:hhs:diva-1083.

Full text

Abstract:

This is the second volume of a dissertation dealing with industrial marketing change processes. The empirical part of the dissertation describes a set of marketing organization changes in Pharmacia Biotech. In 1959 Pharmacia AB launched a completely new separation product for biochemical separation and entered a period of steady growth and development in a completely new business area. By the second half of the 1980s, Pharmacia Biotech AB, subsidiary of the multinational pharmaceutical corporation Pharmacia, had become one of the world's major suppliers of biotech products and services. In 198

APA, Harvard, Vancouver, ISO, and other styles

21

Parisot, Xavier. "Influence des logiques d'innovation ouvertes sur l'émergence des écosystèmes d'affaires dans les Bioindustries françaises." Thesis, Paris, CNAM, 2015. http://www.theses.fr/2015CNAM0996/document.

Full text

Abstract:

Les biotechnologies mobilisées aujourd'hui dans les bioindustries requièrent des compétences qu'une entreprise ne peut plus maîtriser seule. L'aboutissement d'innovations disruptives implique une approche pluridisciplinaire nécessitant l'intervention de plusieurs secteurs industriels ce qui s'oppose à une logique d'innovation propriétaire. La transversalité nécessaire à ces rapprochements entre entreprises privées et secteurs public et ou entre industries issues de secteurs d'activités différents modifie profondément la nature des modèles d'organisation. Parmi l'ensemble des modèles adoptés, c

APA, Harvard, Vancouver, ISO, and other styles

22

Schmidt, Stefan. "Merger and acquisition between small biotech and large pharmaceutical companies - a winning combination? : Case study on the acquisitions of CAT by AstraZeneca and Abgenix by Amgen; MBA thesis in marketing." Thesis, University of Gävle, Department of Business Administration and Economics, 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:hig:diva-3261.

Full text

Abstract:

<p>This study aims at introducing and describing a novel multi parameter analysis method to identify potential acquisition targets and to qualitatively and quantitatively evaluate the overall match between a target company and its acquirer. The method was tested with two recent real cases involving each an antibody based biotech company and a large fully integrated pharmaceutical company. The model was validated by comparing two independent antibody companies against the real cases, testing if they would have made better targets. It was found out that the in reality acquired companies scored h

APA, Harvard, Vancouver, ISO, and other styles

23

Penov, Ivan. "A study of the role of the network of formal agreements in development and commercialization of plant biotechnologies in the United States /." free to MU campus, to others for purchase, 1999. http://wwwlib.umi.com/cr/mo/fullcit?p9953889.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Xiao, Wenbin. "Determinants of new technology-based firms performance in catch-up regions evidence from the u.s. biopharmaceutical and it service industries 1996-2005 /." Diss., unrestricted, 2008. http://etd.gsu.edu/theses/available/etd-07092008-164934/.

Full text

Abstract:

Thesis (Ph. D.)--Georgia Institute of Technology and Georgia State University, 2008.<br>Title from file title page. Philip P. Shapira (Georgia Tech), committee chair; Marco Ceccagnoli, Mary Frank Fox (Georgia Tech); Gregory B. Lewis, John P. Walsh (Georgia State), committee members. Electronic text (146 p. : col. ill., col maps) : digital, PDF file. Description based on contents viewed Sept. 17, 2008. Includes bibliographical references (p. 143-146).

APA, Harvard, Vancouver, ISO, and other styles

25

Guedri, Zied. "Performance variations among strategic group members in the pharmaceutical industry : an examination of individual sustainable growth capabilities, 1995-1997." Thesis, Connect to online version, 1998. http://0-wwwlib.umi.com.mercury.concordia.ca/cr/concordia/fullcit?pMQ39083.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Langer, Lynn Johnson. "How Scientist/Founders Lead Successful Biopharmaceutical Organizations: A Study of Three Companies." [Yellow Springs, Ohio] : Antioch University, 2008. http://www.ohiolink.edu/etd/view.cgi?acc_num=antioch1217337156.

Full text

Abstract:

Thesis (Ph.D.)--Antioch University, 2008.<br>"A dissertation submitted to the Ph.D. in Leadership & Change Program of Antioch University in partial fulfillment of the requirements for the degree of Doctor of Philosophy May 2008."--from the title page. Title from PDF t.p. (viewed July 30, 2008). Advisor: Alan Guskin, Ph.D.. Keywords: biotechnology, biopharmaceutical, leadership, founder, success, management, case study Includes bibliographical references (p. 207-218).

APA, Harvard, Vancouver, ISO, and other styles

27

Scheel, Ramona. "Sustainable Business through Voluntary Disclosures: Motivations for Adopting Reporting Guidance, Boundaries and Assurance." Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden, 2014. http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-135873.

Full text

Abstract:

This paper explores the extent to which corporations currently increase the voluntary disclosures in triple bottom line (TBL) reports. Although research already has provided substantial contributions as to why and how firms apply TBL reporting, there remains limited understanding of the motivations for and against making voluntary disclosures. Drawing from literature in environmental management and accounting as well as international auditing, this work focuses on guidance, boundarysetting and external assurance for TBL reports. An inductive case study approach is applied to investigate the cr

APA, Harvard, Vancouver, ISO, and other styles

28

Cintron, Roberto. "Human Factors Analysis and Classification System Interrater Reliability for Biopharmaceutical Manufacturing Investigations." ScholarWorks, 2015. https://scholarworks.waldenu.edu/dissertations/194.

Full text

Abstract:

Human errors are an expected result of operations performed by individuals and frequently lead to accidents and other catastrophic events. The problem is that the current process used to investigate and mitigate human errors in the biopharmaceutical manufacturing industries is not effective, as it does not include the effects of human factors found to be effective in aviation and nuclear power organizations. The human factors and classification system (HFACS) was created for the investigations of accidents using the Swiss cheese model of accident causation as a theoretical framework. The purpo

APA, Harvard, Vancouver, ISO, and other styles

29

Scheel, Ramona. "Sustainable Business through Voluntary Disclosures: Motivations for Adopting Reporting Guidance, Boundaries and Assurance." Technische Universität Dresden, 2011. https://tud.qucosa.de/id/qucosa%3A27685.

Full text

Abstract:

This paper explores the extent to which corporations currently increase the voluntary disclosures in triple bottom line (TBL) reports. Although research already has provided substantial contributions as to why and how firms apply TBL reporting, there remains limited understanding of the motivations for and against making voluntary disclosures. Drawing from literature in environmental management and accounting as well as international auditing, this work focuses on guidance, boundarysetting and external assurance for TBL reports. An inductive case study approach is applied to investigate the cr

APA, Harvard, Vancouver, ISO, and other styles

30

Jackson, JeShaune D. Jackson. "Bench to Bone: Commercializing a Cellular Therapeutic for Regenerative Medicine." Case Western Reserve University School of Graduate Studies / OhioLINK, 2018. http://rave.ohiolink.edu/etdc/view?acc_num=case1521472107740449.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Kristoffersson, Michelle, and Christina Pettersson. "Outsourcing inom läkemedelsbranschen : Det faktiska utfallet." Thesis, Högskolan i Skövde, Institutionen för handel och företagande, 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-13912.

Full text

Abstract:

Bakgrund: Outsourcing är inget nytt fenomen då transaktionskostnadsteorin formades 1937 som beskrev att företag bör vända sig till marknaden i de fall detta gynnade företaget ekonomiskt. Sedan dess har teorier kring outsourcing förändrats och i dag handlar outsourcing om att kunna fokusera på företagets kärnkompetens och vilka möjligheter och risker outsourcing medför. Läkemedelsbranschen har på senare år börjat outsourca forskning och produktutveckling, vilka ses som kärnprocesser. Det råder därför delade meningar om branschen faktiskt har en kärnprocess. Syfte: Syftet med denna uppsats är at

APA, Harvard, Vancouver, ISO, and other styles

32

Solé, Udina Ernest. "Las estrategias de financiación de las empresas de biotecnología, con referencia al caso español." Doctoral thesis, Universitat de Barcelona, 2019. http://hdl.handle.net/10803/668221.

Full text

Abstract:

Según definición de la OECD (2005), las empresas de biotecnología son aquellas que llevan a cabo alguna de las siguientes actividades: AND/ARN: genómica, farmacogenómica; Secuenciación/síntesis/ingeniería de proteínas y otras moléculas; Cultivo de células y tejidos, e ingeniería;Técnicas de procesos biotecnológicos;Vectores genéticos y de ARN;Terapia génica y vectores virales; Bioinformática; Nanobiotecnología. A efectos de este trabajo, se definen dos grupos de empresas de biotecnología: Empresa dedicada a la biotecnología, cuya actividad principal implica la apliación de técnicas biotecnológ

APA, Harvard, Vancouver, ISO, and other styles

33

Lattemann, Christoph, and Stefan Stieglitz. "Einsatz Virtueller Welten in der Aus- und Weiterbildung – Das Projekt Bio-VWe." Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden, 2014. http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-141245.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Oliveira, Maria Fernanda de. "Gestão da informação e inteligência competitiva em empresas de biotecnologia do Brasil." Universidade Federal de São Carlos, 2012. https://repositorio.ufscar.br/handle/ufscar/1082.

Full text

Abstract:

Made available in DSpace on 2016-06-02T19:16:31Z (GMT). No. of bitstreams: 1 4199.pdf: 4332422 bytes, checksum: 41c61382913977b470cc814745cb5246 (MD5) Previous issue date: 2012-02-15<br>Universidade Federal de Minas Gerais<br>Through the perception of the value and potential of Biotechnology for Brazil and the lack of studies concerning politics, economy and social affairs in this area, this research has the intention of studying the Biotechnology companies from the point of view of their information management and relationship with Financiadora de Estudos e Projetos (FINEP), major sponsor,

APA, Harvard, Vancouver, ISO, and other styles

35

Lattemann, Christoph, and Stefan Stieglitz. "Einsatz Virtueller Welten in der Aus- und Weiterbildung – Das Projekt Bio-VWe." Technische Universität Dresden, 2008. https://tud.qucosa.de/id/qucosa%3A27944.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Bloom, Connor. "The Feasibility of Whole-Blood-System Genotyping: A Case Study using the San Diego Blood Bank." Scholarship @ Claremont, 2019. https://scholarship.claremont.edu/cmc_theses/2110.

Full text

Abstract:

Over the past several decades and increasingly in recent years, blood transfusions in the United States have plummeted as surgery has gotten more precise and less invasive. Alongside this decrease in general transfusions has been an increase in specific blood products for patients whose immune systems require special treatment. Simultaneously, trends in healthcare in the United States have incentivized regional hospitals to join large conglomerates. These coexisting factors have left regional blood banks, traditionally economically viable, in much weakened states. This thesis was born out of a

APA, Harvard, Vancouver, ISO, and other styles

37

Rasmussen, Bruce. "Creating and capturing value in the biopharmaceutical sector." Thesis, full-text, 2008. https://vuir.vu.edu.au/1946/.

Full text

Abstract:

This study addresses the ongoing implications of the realignment of the pharmaceutical industry knowledge base – from small molecule methods to new biomedical technologies – for the competitive positions of traditional pharmaceutical companies and biopharmaceutical start-ups. The theoretical approach draws on the modern theory of the firm and related concepts, to define and develop the concept of the business model. This is employed to guide the empirical analysis, which utilises a combination of data analyses and case studies based on several sources, including detailed company reports and al

APA, Harvard, Vancouver, ISO, and other styles

38

de, Paula Reis Alline. "Conception biologique complexe : Planification et modèles d'affaires. Le cas du clonage équin. Conception et planification dans les biotechnologies innovantes : le clonage équin." Thesis, Paris, AgroParisTech, 2013. http://www.theses.fr/2013AGPT0076.

Full text

Abstract:

Les sciences du vivant ont connu des développements technologiques importants dans les dernières décennies. Dans les années 90 et 2000 le monde a assisté à l'apparition de plusieurs technologies a priori prometteuses telles que le clonage de mammifères, la transgénèse animale et végétale ou encore les traitements thérapeutiques par des cellules souches. La littérature spécialisée dans le domaine est riche en publications sur les aspects technico-expérimentaux de ces technologies et, malgré la difficulté technique encore apparente dans les publications, les auteurs sont optimistes quant à la ré

APA, Harvard, Vancouver, ISO, and other styles

39

WU, KUAN-JU, and 吳冠儒. "Taiwan Sericulture Biotechnology Business Plan." Thesis, 2017. http://ndltd.ncl.edu.tw/handle/522vex.

Full text

Abstract:

碩士<br>國立雲林科技大學<br>創業管理碩士學位學程<br>105<br>The long forgotten sericulture industry; Sericulture industry was very flourishing in the 1970-1980s. The exportation of silkworm cocoon to Japan constituted a large portion of the profit for the industry. However, due to the Japanese started to import silkworm cocoon from China, and the lack of innovative and high value products, the sericulture industry in Taiwan had diminished ever since. This business plan aims to enhance the economic value of sericulture industry by utilizing innovative and exclusive technologies to extract silk protein from silkworm

APA, Harvard, Vancouver, ISO, and other styles

40

Van, Heerden Philippus Johannes. "A business model for biotechnology enterprises in South Africa." Thesis, 2012. http://hdl.handle.net/10210/6286.

Full text

Abstract:

D.Comm.<br>The mission of the research is to design a South African biotechnology business model that could be widely embraced by various biotechnology enterprises. The business model advises biotechnology enterprises on the applicable strategy to follow and addresses both internal and external factors important to biotechnology enterprises. Contrary to common beliefs, biotechnology has been utilised for thousands of years. The biotechnology markets in the United States, Europe, Canada and Asia/Pacific are increasingly moving operations beyond country borders to achieve business efficiency. A

APA, Harvard, Vancouver, ISO, and other styles

41

Moodley, Nivan. "Competitiveness of South Africa’s biotechnology sector." Diss., 2009. http://hdl.handle.net/2263/23175.

Full text

Abstract:

In 2001, the South African government developed a biotechnology strategy and set aside approximately $70 million to support and stimulate the development of biotechnology skills, capabilities and tools in South Africa(Campbell, 2007). During the past seven years, since the strategy‟s inception, no independent qualitative analysis has been conducted, which could provide insights into its strengths, weaknesses and the views of the different stakeholders within the industry as to the degree of stimulation and competitiveness the strategy as achieved. Competitiveness at a nation level is best desc

APA, Harvard, Vancouver, ISO, and other styles

42

Chen, Mei-Ju, and 陳玫汝. "Business Model Analysis of Biotechnology and Medical Companies in Taiwan." Thesis, 2004. http://ndltd.ncl.edu.tw/handle/12662089558365979531.

Full text

Abstract:

碩士<br>國立臺灣大學<br>國際企業學研究所<br>92<br>Under the favorable policy support and a well-established legal environment, the biotechnology and medical industry in developed countries prosper with vigorous market growth and leading technologies. In the past, only few very large pharmaceutical companies were able to finish the whole process of new drug research and development on their own. In contrast, the trend is towards specialization in a particular section of the value chain. The specialization allows small biotech companies to focus on and leverage their core competences through strategic alliance

APA, Harvard, Vancouver, ISO, and other styles

43

Chiu, Feng-Hsuan, and 邱逢弦. "A STUDY ON BIOTECHNOLOGY INDUSTRIAL STRATEBIC MATRIX AND BUSINESS STRATEGY." Thesis, 2002. http://ndltd.ncl.edu.tw/handle/56812535376280605294.

Full text

Abstract:

碩士<br>國立臺北大學<br>企業管理學系<br>90<br>Recent discoveries in biotechnology are propelling exciting and revolutionary advances in the biotechnology industry especially in the research and development process. Due to personal interest and educational background, I hope to construct a biotechnology industrial strategic matrix to analyze the whole environment and the strategies employed by existing biotechnological firms. First, using analytic hierarchy process (AHP), I selected the most important two dimensions which have influenced the biotechnology industry to form the strategic matrix. In

APA, Harvard, Vancouver, ISO, and other styles

44

Lin, Hao-chun, and 林浩群. "A Study on Business Marketing Strategy of Agricultural Biotechnology Industry." Thesis, 2010. http://ndltd.ncl.edu.tw/handle/46372257463068221758.

Full text

Abstract:

碩士<br>國立臺南大學<br>科技管理研究所在職專班<br>98<br>Based on published United Nations report estimated that the global population in 2009 is 6.8 billion and in 2050 will be a breakthrough to 9.0 billion. At that time, pigs, poultry and sheep meat and other major demand will be significantly enhanced and biotechnology will be the one solution. Agricultural development in Taiwan has deep experience and using biotechnology to develop high value-added agriculture must be a future trend. We can expect the future of agricultural biotechnology industry will become the new mainstream industry in Taiwan. Based on the

APA, Harvard, Vancouver, ISO, and other styles

45

Hsieh, Tien-Wei, and 謝天瑋. "A Case Study on Business Strategy of Taiwan Biotechnology Industry." Thesis, 2009. http://ndltd.ncl.edu.tw/handle/61588812608588307121.

Full text

Abstract:

碩士<br>國立勤益科技大學<br>企業管理系<br>97<br>Due to effects of economic globalization and free economy, after Taiwan joined the World Trade Organization, WTO, it was obliged to abide by regulations as a member nation. Restrictions on imports of commodities were lifted one after another. In the face of fierce competition from overseas suppliers, Taiwanese enterprises either underwent transformation or diversified development in order to ensure sustainable development. Since the government targeted the biotechnology industry as one of the scopes of the Two Trillion Twin Star Project, biotechnology continued

APA, Harvard, Vancouver, ISO, and other styles

46

Chung, Hui-I., and 鍾慧儀. "A Study on Business Risk Management for Biotechnology Industry in Taiwan." Thesis, 2003. http://ndltd.ncl.edu.tw/handle/78066555933251363323.

Full text

Abstract:

碩士<br>國立高雄第一科技大學<br>風險管理與保險所<br>91<br>ABSTRACT Questionaire survey and stastical analysis are conducted in this study in order to detect the awareness and strategy of business risk management in the high-tech sector of biotechnology industry in Taiwan. Several key issues are identified in this study through descriptive statistics, element analysis and variance aanalysis. This study indicates that the awareness of business risk management for Taiwan biotech-sector changes with (1) company core technologies and spectrum, (2) industrial history and experience of a company, and (3) education

APA, Harvard, Vancouver, ISO, and other styles

47

Huang, Tung-Hung, and 黃同弘. "A Study of Taiwan IT companies business strategy in biotechnology industry." Thesis, 2004. http://ndltd.ncl.edu.tw/handle/99896913413791653054.

Full text

Abstract:

碩士<br>國立中山大學<br>國際高階經營管理碩士班<br>92<br>For the biotechnology industry in Taiwan, government gives fresh impetus to biotechnology industry, which makes it becoming a chief one in next stage. The biotechnology industry is also a priority event in “The challenge to year 2008 nation development significant plan”. IT is a matual industry in Taiwan. Thought the biotechnology is the star industry in next stage, but there is a question existed for all IT companies, how to invest in biotechnology? Bioinformatics seems to be the answer to the question. But is it the right answer? Are there any success sto

APA, Harvard, Vancouver, ISO, and other styles

48

CHEN, WEN-JEN, and 陳威仁. "The business model innovation of biotechnology industry: Towards an integrated approach." Thesis, 2019. http://ndltd.ncl.edu.tw/handle/9f4v55.

Full text

Abstract:

博士<br>長榮大學<br>經營管理研究所<br>108<br>In recent years, business model innovation has received greater attention by the academic field. Hence, this research takes companies in biotechnology industry as samples to conduct process-oriented and innovation-oriented comprehensive research with three sub-studies. This research focused on theory of business model innovation, and illustrated the change process of business model evolution. Further, it illustrates the influences from external environment, how business model change, the driving and limiting factors of change, how to survive and maintain competi

APA, Harvard, Vancouver, ISO, and other styles

49

Demirkan, Irem. "Essays on the evolution of networks in the U.S. biotechnology industry /." 2007. http://proquest.umi.com/pqdweb?did=1464120111&sid=1&Fmt=2&clientId=10361&RQT=309&VName=PQD.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Cheng, Kuang-Chuan, and 鄭光泉. "The Business Competitive Advantage and the Structure of Innovation Business Model on Taiwan Biotechnology and Pharmaceutical Industries." Thesis, 2003. http://ndltd.ncl.edu.tw/handle/83772965972648828253.

Full text

Abstract:

碩士<br>國立中山大學<br>高階經營碩士班<br>91<br>Keywords：Biotechnology, Business Competitive Advantage, Innovation Business Model, Strategic Marketing, Marketing Concept Rests on Four Pillars, Porter’s Competitive Forces Model, Value-chain Model, Resources Advantage Orientation, Resources-Based Theory( view) , Core Competence, Customer Relation Management, Strategy Game Due to entrance of WTO and performance of cGMP, Taiwan’s biotechnology and pharmaceutical industries has met with more challenge、impact and pressure that let enterprise must reflect the marketing concept rests on four pillars：target market, c

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!